SPXL:ARCA-Direxion Daily S&P 500 Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 110.64

Change

+0.25 (+0.23)%

Market Cap

USD 0.55B

Volume

6.76M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P 500? Index. The fund, under normal circumstances, creates long positions by investing at least 80% of its assets in the securities that comprise the S&P 500? Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments. The index is a capitalization-weighted index composed of 500 common stocks. The fund is non-diversified.

Inception Date: 05/11/2008

Primary Benchmark: S&P 500 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-17 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 8.14B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.07B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.37B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.08B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 1.95B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.19B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 0.82B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.66B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.59B

ETFs Containing SPXL

DRAI Draco Evolution AI ETF 5.12 % 0.00 %

N/A

USD 0.01B
GTAA 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -34.42% 27% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.42% 27% F 6% D-
Trailing 12 Months  
Capital Gain -4.23% 55% F 35% F
Dividend Return 0.46% 21% F 6% D-
Total Return -3.77% 54% F 29% F
Trailing 5 Years  
Capital Gain 218.30% 87% B+ 91% A-
Dividend Return 7.08% 60% D- 15% F
Total Return 225.38% 85% B 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 36.82% 68% D+ 92% A
Dividend Return 37.47% 68% D+ 91% A-
Total Return 0.64% 44% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 65.66% 54% F 12% F
Risk Adjusted Return 57.06% 82% B 71% C-
Market Capitalization 0.55B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.